Wednesday, Jul 23, 2014 12:08 pm est

Professor of microbiology earns White House honors

Posted on February 4, 2013 | by Hanqing Chen

Jan Vilcek, an NYU professor of microbiology, launched his medical research career on a hunch and spent his career researching the power of the human body’s natural arsenal of antibodies.

Once a Czechoslovakian medical student who defected to the United States during the tumultuous post-World War II era, Vilcek brought his research to NYU in 1965. He pioneered work on an elusive, natural antibody called the interferon. The study eventually allowed him to lead a team of researchers to develop Remicade, a drug that eases the symptoms of certain autoimmune diseases.

His work most recently gained recognition on the national stage last Friday, as President Obama awarded Vilcek the National Medal of Technology and Innovation at a reception at the White House. The award is one of the highest honors the U.S. government can grant American scientists. Vilcek was one of 12 recipients this year.

Vilcek’s medication is commonly used to treat symptoms of Crohn’s disease and rheumatoid arthritis and is used by over two million patients nationwide.

Vilcek’s career took off after he stumbled upon a lecture by medical researcher Alec Isaacs. Isaacs was promoting an idea that seemed far-fetched to many researchers at the time — the idea that the interferon could have a very significant effect on people’s health.

“[The interferon] was very poorly defined,” Vilcek said, recalling the academic atmosphere when he was a university student in Czechoslovakia. “All the tests for it were indirect, so there were very few people in- terested in working on it … Some people even doubted it existed.”

However, Vilcek believed in the existence of this natural antibody despite widespread aca- demic skepticism in the medical field at the time. He kept the idea in the back of his mind as he continued his research.

Incorporating interferons as a key part of the body’s defense mechanism returned to him when he experimented on ways to identify the presence of the tick-borne encephalitis virus.

“It suddenly occurred to me that maybe [the] interferon played a role in this particular type of experiment that I was doing,” he said.

The discovery of its significance eventually sparked Vilcek and other researchers to look into the larger family of antibodies called cytokines, the overproduction of which causes certain types of arthritis.

As the puzzle pieces of how cytokines worked in the body came together, researchers began to develop the drug. Vilcek and his research partner, Junming Le, joined forces with a biomedical research company called Centercor to develop Remicade, the Crohn’s disease drug treatment.

Claudio Basilico, a colleague and friend of Vilcek’s for over 40 years, spoke of his complete confidence in Vilcek’s research early on.

“He was one of the researchers I definitely wanted to keep when the microbiology department shrank,” Basilico said. “He is a very intelligent and persevering man.”

In fact, Vilcek faced several setbacks during initial clinical trials as they failed to produce viable results.

“Thankfully we had the support of researchers in London,” Vilcek said.

The process of developing the drug took over a decade, and it was finally released to the market in 1998.

Recently, Vilcek and his wife established the Vilcek Foundation to help recognize foreign-born scientists’ and artists’ contributions to the U.S.

“Dedicated to advancing science and medical education, Dr. Vilcek has used his success to inspire the next generation of physician scientists at NYU Langone to be vital member[s] of the medical center’s community,” said Robert I. Grossman, dean and CEO at NYU Langone.

A version of this article appeared in the Monday, Feb. 4 print edition. Hanqing Chen is web managing editor. Email her at 


profile portrait
Felipe De La Hoz

Multimedia Editor | Felipe De La Hoz is a Colombian national studying journalism at the College of Arts and Sciences. Having been born in Colombia and raised in the United States, Mexico and Brazil, Felipe is a trilingual travel aficionado and enjoys working in varied and difficult environments. Apart from his photography, Felipe enjoys investigative reporting and interviews, interviewing the likes of Colombian ex-M-19 guerrilla fighters and controversial politician Jimmy McMillan. He has covered everything from governmental conferences to full-blown riots, as well as portraiture shoots and dining photography. Having worked under Brazilian photojournalists for Reuters and AFP, Felipe hopes to one day work on demanding journalistic projects and contribute to the global news cycle.

Ann Schmidt

News Editor | Ann is a liberal studies sophomore who lived in Florence during her freshman year. She plans on double-majoring in journalism and political science and is always busy. She is constantly making lists and she loves to laugh.


Daniel Yeom

Daniel started at the Features desk of WSN last Spring, writing restaurant reviews whilst indulging on free food and consequently getting fat. Last Fall, he was the dining editor, and he this semester he is senior editor. Daniel is in Gallatin (living the dream) studying Food & Travel Narratives, incorporating aspects of Food Studies, Journalism, and Media, Culture, and Communication. He loves food more than life itself.

Hannah Luu

Deputy Multimedia Editor | Hannah Luu is a ridiculously great Deputy Multimedia Editor. She is a sophomore from Northern California. If you think Northern California means San Francisco you might need to closely examine a map. She is passionate about NPR and being half Asian.

  • How to join:

    The Washington Square News holds open weekly budget meetings at its office located at 838 Broadway every Sunday. All are welcome to attend, no matter your background in journalism, writing, or reporting. Specific times for meetings by desk are listed below. If you wish to talk to an editor before you attend, feel free to check out the Staff page.

    5 P.M. 6 P.M. 6 P.M. 6:30 P.M. 6:30 P.M. 7 P.M.

    Applying for an editor position: Applications for editor positions during the fall or spring semesters are available twice each academic year and can be found here when posted. Applications for the Fall 2012 semester are closed, but check back for Spring 2013. Those who wish to apply are urged to publish pieces in the newspaper and contact current editors for shadowing.

    History of the Washington Square News:

    The Washington Square News is the official daily student newspaper of New York University and serves the NYU, Greenwich Village, and East Village communities. Founded as an independent newspaper in 1973, the WSN allows its undergraduate writers and photographers to cover campus and city news and continues to grow its strong body of award-winning journalists and photographers.

  • The WSN has a circulation of about 60,000 and can be found in over a hundred purple bins distributed throughout campus. It is published Monday through Thursday during the fall and spring semesters and online on Friday, with additional special issues published in the summer. The newspaper recently revamped its website during the Fall 2012 semester.

    Like few campus newspapers in the country, the paper is editorially and financially independent from the university and is solely responsible for selling advertisements to fund its production. The WSN, including its senior staff, is run solely by current undergraduate students and the business-division is largely student-operated as well.

    A Board of Directors comprised of alumni, NYU professors and working news media professionals serves as advisors to the paper. Board members have no control in the WSN's editorial policy or newsroom operations. Alumni of the newspaper are established and leading journalists in such news organizations as The New York Times, The Wall Street Journal, NBC news, ABC news, Fox News, and USA Today.